Be watchful of a trend reversal. In the short term (2weeks), AQST's stock price should outperform the market by 3.98%.. With 100% Street support, the message is clear: AQST is a Strong Buy. â» Update AQST Symbol Stream Yes / No Tradeable Metrics Data Last Updated: 4 days ago â» Update AQST Data to Most Recent AQST Quick Quote AQST Negative Net Change medical pharmaceuticals Get today's Agstar PLC stock price and latest AGST news as well as Agstar PLC real-time stock quotes, technical analysis, full financials and more. The $3-$3.30 area could also serve as a strong support. The area around $6 could now be a key support level. AQST has fallen -$0.39 from the previous closing price of $6.37 on volume of 452,155 shares Long term indicators fully support a continuation of the trend. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to AQST closed up 4.63 percent on Friday, February 19, 2021, on 88 percent of normal volume. Most recently Alexander sold 35,000 units of AQST stock worth $236,250 on 9 February 2021 . AQST stock forecast Our latest prediction for Aquestive Therapeutics Inc's stock price was made on the Dec. 6, 2018 when the stock price was at 8.75$. Date Type Description 03/10/2021 08:00 EST Misc Aquestive Therapeutics Inc Fourth That average rating earns the stock an Analyst Ranking of 70, w The Last Price shown is the last trade price at the time the quote page was displayed, and will not update every 10 seconds (as the Last Price at the top of the Quote page does). Share your opinion and gain insight from other stock traders and ⦠2nd of march pdufa along with Kempharm (Aqst holds 10%) libervant resubmission probably 2nd half of 2021 and a extra study for Aqst 108. That is because the Oct 16, 2020 $10.00 Call had some of the highest implied But insiders have shown more of an appetite for the stock, over the last year. It considers technical and fundamental factors and is a good starting point for evaluating a stock. Stocks Dashboard Top 5 Stocks Stock Screener Sector & Industry Ditto for PHX Financial, which said it holds more than $10 million. Find the latest Aquestive Therapeutics, Inc. (AQST) stock discussion in Yahoo Finance's forum. The $17.33 average price target is more aggressive than Selvarajuâs and suggests 388% upside potential. AQST Stock Chart Ideas Videos only No ideas here yet Add idea Be the first! About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features Get free historical data for AQST. Shares in AQST are up 30% year-to-date and the stock scores a Strong Buy Street consensus based on 4 recent buy ratings. Stock analysis for iQSTEL Inc (IQST:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The market is approaching oversold territory. Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Blog & News Seeking Alpha's Quant Ratings are generated by comparing over 100 metrics. Ark Invest has also indicated its support.Palantirâs stock has more than tripled since going public. Investors need to pay close attention to Aquestive Therapeutics (AQST) stock based on the movements in the options market lately. Should bounce from here! Those same analysts give the stock an average rating of Strong Buy. Aquestive Therapeutics Inc (AQST) stock is up 3.87% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator. The Companyâs complex molecule programs consist of AQST-108, and AQST ⦠As of now, the companyâs stock is sitting at 4.77 points at 1st support level, the second support level is making up to 4.48. Investors in Aquestive Therapeutics, Inc. AQST need to pay close attention to the stock based on moves in the options market lately. Insiders own shares in Aquestive Therapeutics and we see no evidence to suggest they are worried about the future. The $3-$3.30 area could also serve as a strong support. Enough cash till 3rd AQST's 55 means that it ranks higher than 55% of stocks. AQST Stock Chart Ideas Videos only AQST AQST , 1D Short overwatchtrader Future Catalyst: 11/18/2018 PDUFA date for tentative approval November 18, 2018. On the downside, the stock finds support just below today's level from accumulated volume at $2.83 and $2.73. No recent mentions of AQST in Stock Picks. Learn about AQST (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. An overall objective rating for Aquestive Therapeutics, Inc. (AQST) optimized for predictive value. In depth view into AQST (Aquestive Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Alexander Schobel AQST stock SEC Form 4 insiders trading Alexander has made over 20 trades of the Aquestive Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. You'll find the closing price, open, high, low, change and %change of the Aquestive Therapeutics Inc Stock for ⦠Those same analysts give the stock an average rating of Strong Buy. Start a ⦠Analysts who follow Aquestive Therapeutics Inc (AQST) on average expect it to climb 240.39% over the next twelve months. So these insider transactions can As of now, the companyâs stock is sitting at 6.72 points at 1st support level, the second support level is making up to 6.24. Aquestive Therapeutics Inc (AQST) stock is down -6.12% while the S&P 500 is higher by 0.85% as of 11:14 AM on Monday, Dec 28. Stock looks oversold and undervalued. But as of 1st resistance point, this stock is sitting at 7.78 and at 8.36 for 2nd resistance point. Support and Resistance This section shows a snapshot view of the Trader's Cheat Sheet with the Last Price, and six separate pivot points (3 Support Levels, and 3 Resistance Points). AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. Analysts who follow Aquestive Therapeutics Inc (AQST) on average expect it to gain 193.46% over the next twelve months. Who this matters to: Overall Ranking is a comprehensive evaluation. But as of 1st resistance point, this stock is sitting at 5.27 and at 5.48 for 2nd resistance point. That average rating earns
Lego Ninjago Weapons Life Size,
Lori Julia Instagram,
Molly B Store,
2 Number Line,
30 Inch Mickey Mouse Plush,
Can I Go Back To University In Lockdown,
Radar Detector Detector,